LONGBOARD PHARMACEUTICALS IN
COM · Common Stock · CUSIP 54300N103
18
institutional holders
-5 vs Q1 2021
8.0m
shares reported held*
$71.7mreported value*
5 new
3 added
6 reduced
9 sold out
net sold ≈ $8.2m (-901.9k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.99.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 23 |
| Q2 2021 | 18 |
Biggest buyers
| VANGUARD GROUP INC | Added | +110.5k |
| FMR LLC | Added | +44.7k |
| BlackRock Inc. | New | +18.0k |
| RENAISSANCE TECHNOLOGIES LLC | New | +10.4k |
| UBS Group AG | Added | +2.6k |
| Advisory Services Network, LLC | New | +1.0k |
| Tower Research Capital LLC (TRC) | New | +38 |
| WELLS FARGO & COMPANY/MN | New | +33 |
Biggest sellers
| CITIGROUP INC | Sold out | -405.6k |
| ORBIMED ADVISORS LLC | Reduced | -186.5k |
| CITADEL ADVISORS LLC | Sold out | -181.5k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -135.9k |
| Alyeska Investment Group, L.P. | Reduced | -39.6k |
| Cormorant Asset Management, LP | Reduced | -34.6k |
| GOLDMAN SACHS GROUP INC | Sold out | -25.0k |
| Endurant Capital Management LP | Sold out | -16.3k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -15.5k |
| ExodusPoint Capital Management, LP | Sold out | -15.0k |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| Cormorant Asset Management, LP 0.81% of their portfolio | 2.3m $20.9m | Reduced -34.6k |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 2.3m $20.1m | Reduced -15.5k |
| FMR LLC 0.00% of their portfolio | 2.0m $18.6m | Added +44.7k |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.04% of their portfolio | 810.5k $7.4m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 165.5k $1.5m | Added +110.5k |
| ORBIMED ADVISORS LLC 0.01% of their portfolio | 113.5k $1.0m | Reduced -186.5k |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 85.4k $778.0k | Reduced -39.6k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 54.4k $497.0k | Reduced -135.9k |
| Integral Health Asset Management, LLC 0.08% of their portfolio | 30.0k $274.0k | Unchanged |
| Laurion Capital Management LP 0.00% of their portfolio | 20.9k $191.0k | Reduced -3.5k |
| BlackRock Inc. 0.00% of their portfolio | 18.0k $164.0k | New |
| TD Asset Management Inc 0.00% of their portfolio | 17.0k $153.0k | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 10.4k $95.0k | New |
| UBS Group AG 0.00% of their portfolio | 3.2k $29.0k | Added +2.6k |
| Advisory Services Network, LLC 0.00% of their portfolio | 1.0k $9.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 38 $0 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 33 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |